awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q26863418-0596982E-374D-483A-B097-A31FBD9CCCCD
Q26863418-0596982E-374D-483A-B097-A31FBD9CCCCD
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26863418-0596982E-374D-483A-B097-A31FBD9CCCCD
Hampering immune suppressors: therapeutic targeting of myeloid-derived suppressor cells in cancer
P2860
Q26863418-0596982E-374D-483A-B097-A31FBD9CCCCD
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26863418-0596982E-374D-483A-B097-A31FBD9CCCCD
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
de2d1b8cce0ea6ff8f5731f3a4c37abc85348ba6
P2860
Rosiglitazone and Gemcitabine in combination reduces immune suppression and modulates T cell populations in pancreatic cancer.